Abstract 1903: Reported behavior of eating anything at anytime and risk of colorectal cancer in women

Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
International Journal of Cancer (Impact Factor: 5.09). 07/2011; 130(6):1395-400. DOI: 10.1002/ijc.26150
Source: PubMed


Although numerous studies have assessed the effect of foods and nutrients on colorectal carcinogenesis, few studies have investigated human eating behavior in relation to risk of colorectal cancer. In our study, we assessed whether the reported behavior of eating anything at anytime influenced colorectal cancer risk and related plasma biomarkers. We prospectively followed up 55,540 women in the Nurses' Health Study who were aged 48-73 years, had no history of cancer, ulcerative colitis or diabetes and responded to the item "I eat anything I want, anytime I want" in the 1994 questionnaire. We also analyzed blood samples for 1,994 women, which were collected in 1989-1990. During 12 years of follow-up, 552 colorectal cancer cases were documented. After adjusting for age, smoking, body mass index, physical activity, red and processed meat and other known risk factors for colorectal cancer, women who reported eating anything at anytime experienced an increased risk of colorectal cancer (relative risk = 1.28, 95% confidence interval = 1.06-1.56) compared to those who did not report this behavior. In addition, reporting eating anything at anytime was associated with higher fasting plasma levels of insulin (p = 0.04) and C-peptide (p = 0.05). In conclusion, reports of eating anything at anytime are associated with an increased risk of colorectal cancer in this large prospective cohort study, independent of other potential risk factors for colorectal cancer.

Full-text preview

Available from:
  • [Show abstract] [Hide abstract]
    ABSTRACT: Tumorassoziierte Ernährungsprobleme werden meist auf die Entwicklung einer Kachexie im Verlauf schwerer Erkrankungen reduziert: Der erhöhte Energiebedarf der Tumorzellen, die verminderte Nahrungsaufnahme bei Inappetenz, Schluckbeschwerden und Stenosierungen des Verdauungstrakts sowie die verminderte Nahrungsverwertung bei Mitbeteiligung des Verdauungstrakts führen häufig zu einer deutlichen Gewichtsreduktion, die aber schon vor Erreichen einer Kachexie zu therapeutischen Maßnahmen führen muss. Da Fehl- und Überernährung zur Entstehung von Karzinomen beitragen, muss im Sinne einer Sekundärprävention bei definierten Patientengruppen auch eine Gewichtsreduktion bzw. eine Ernährungsumstellung erfolgen. In diesem Artikel werden die Grundsätze der im Sinne einer Tumorprävention gesunden Ernährung und wichtige Sonderfälle tumorbedingter Ernährungsprobleme beschrieben. Die stationäre onkologische Rehabilitation kann die Patienten bei der gewünschten Lebensstiländerung wesentlich unterstützen. Tumor-associated nutritional problems often lead to the development of a cachectic state during the severe course of diseases. The increased energy consumption of the tumor cells, decreased appetite, swallowing difficulties, intestinal stenosis and decreased absorption of nutrients often lead to severe loss of weight, which needs therapeutic attention before reaching cachexia. However, as malnutrition and overnutrition contribute to the development of carcinomas, some groups of patients also have to undergo weight reduction and dietary changes for secondary prevention. The principles of a tumor prophylactic, healthy diet, as well as important causes of tumor-associated nutritional problems are described in this article. Inpatient oncologic rehabilitation can play an essential role in necessary lifestyle modifications for these patients. SchlüsselwörterErnährung–Kachexie–Mangelernährung–Krebs–Adipositas KeywordsNutrition–Cachexia–Malnutrition–Cancer–Obesity
    Der Onkologe 10/2011; 17(10):906-912. DOI:10.1007/s00761-011-2110-0 · 0.14 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Colorectal cancer (CRC) is one of the leading cancers and cause of cancer deaths in American women and men. Females and males share a similar lifetime cumulative risk of CRC however, substantial differences in risk factors, tumor biology, and effectiveness of cancer prevention services have been observed between them. This review distills the evidence documenting the unique variation observed between the genders relating to CRC risk factors, screening and prevention. Consistent evidence throughout the world demonstrates that women reach equivalent levels of adenomas and CRC as men but it occurs nearly a decade later in life than in their male counterparts. Women have a higher proportion of tumors which are hypermethylated, have microsatellite instability and located in the proximal colon suggesting the serrated pathway may be of greater consequence in them than in men. Other CRC risk factors such as smoking, diet and obesity have been shown to have disparate effects on women which may related to interactions between estrogen exposure, body fat distribution, and the biologic underpinnings of their tumors. There is data showing the uptake, choice, and efficacy of different CRC screening methods in women is dissimilar to that in men. The mortality benefit from FOBT, sigmoidoscopy, and protection from interval CRC by colonoscopy appears to be lower in women than men. A greater understanding of these gender idiosyncrasies will facilitate an personalized approach to CRC prevention and should ultimately lead to a reduced burden of disease.
    Digestive Diseases and Sciences 01/2015; 60(3). DOI:10.1007/s10620-014-3452-4 · 2.61 Impact Factor